Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/ valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: Results fromPARADIGM-HF

Michael Böhm, Robin Young, Pardeep S. Jhund, Scott D. Solomon, Jianjian Gong, Martin P. Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor C. Shi, Karl Swedberg, Michael R. Zile, Milton Packer, John J.V. McMurray